2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$6.24+$0.09 (+1.51%)
Price as of Aug 21, 2026 7:57 PM EDT- $77.2MMarket Cap
- 148.99%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$6.24+$0.09 (+1.51%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.15 | ||
Change | -$0.12 (-1.91%) | ||
Open | $6.27 | ||
High | $6.34 | ||
Low | $6.15 | ||
Previous Close | $6.27 | ||
Volume | 96,703 | ||
30-Day Average Volume | 96,299 | ||
1-Week Change | -2.38% | ||
1-Month Change | -12.27% | ||
1-Year Change | 148.99% | ||
3-Year Change | 19.42% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.6M | ||
Total Assets | $10.0M | ||
Market Cap | $77.2M | ||
Enterprise Value | $69.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$2.1M | ||
Free Cash Flow | -$1.0M | ||
EBIT | -$2.1M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $6.3M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 11 | ||
P/E | -32 | ||
PEG | 6 | ||
Price/Free Cash Flow | -75 | ||
Price/Operating Cash Flow | -75 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue